Flumazenil Injection Shortage
Last Updated: May 3, 2024
Status: Current
Products Affected - Description
-
- Flumazenil injection, Baxter, 0.1 mg/mL, 5 mL vial, 10 count, NDC 36000-0148-10
- Flumazenil injection, Fresenius Kabi, 0.1 mg/mL, 10 mL vial, 1 count, NDC 63323-0424-10
- Flumazenil injection, Fresenius Kabi, 0.1 mg/mL, 5 mL vial, 10 count, NDC 63323-0424-05
- Flumazenil injection, Hikma, 0.1 mg/mL, 10 mL vial, 10 count, NDC 00143-9783-10
- Flumazenil injection, Hikma, 0.1 mg/mL, 5 mL vial, 10 count, NDC 00143-9784-10
Reason for the Shortage
-
- Baxter did not provide a reason for the shortage.
- Fresenius Kabi did not provide a reason for the shortage.
- Hikma did not provide a reason for the shortage.
Available Products
-
- Flumazenil injection, Baxter, 0.1 mg/mL, 10 mL vial, 10 count, NDC 36000-0149-10
Estimated Resupply Dates
-
- Baxter has flumazenil 0.1 mg/mL 5 mL vials on back order and the company estimates a release date of mid-May 2024.
- Fresenius Kabi has flumazenil 0.1 mg/mL 5 mL and 10 mL vials on back order and the company estimates a release date of mid-May 2024.
- Hikma has flumazenil 0.1 mg/mL 5 mL and 10 mL vials on back order and the company estimates a release date of late-July to early-August 2024.
Updated
Updated May 3, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 4, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.